Letter from Applicant dated 09-JUL-2014 re: advising that they have reached an agreement on the quantum of costs with the other parties received on 09-JUL-2014

Acknowledgment of Receipt received from all parties with respect to Prohibition Order Doc. 27 and confirmation (by e-mail) that the Hearing dates have been released by the Judicial Administrator. placed on file on 29-OCT-2013

Prohibition Order dated 29-OCT-2013 rendered by The Honourable Mr. Justice de Montigny Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 24-OCT-2013 re: revised draft order Result: granted "1. The Minister of Health is prohibited from issuing a Notice of Compliance under section C.08.004 of the Food and Drug Regulations to Cobalt Pharmaceuticals Company in connection with its 4mg/5mL zoledronic acid concentrate solution for intravenous infusion until after expiration of Canadian Patent 1,338,937; 2. The Minister of Health is prohibited from issuing a Notice of Compliance under section C.08.004 of the Food and Drug Regulations to Cobalt Pharmaceuticals Company in connection with its 5mg/100mL zoledronic acid solution for intravenous infusion until after expiration of Canadian Patent 1,338,937; 3. No Prohibition Order is issued with respect to Canadian Patent 1,338,895; 4. The Applicant Novartis Pharmaceuticals Canada Inc. shall recover its costs from Cobalt Pharmaceuticals Company in the amount of $35,000; and 5. No costs are payable by the Minister." Identical Order issued in T-724-12 Filed on 29-OCT-2013 copies sent to parties and the Minister of Health entered in J. & O. Book, volume 1208 page(s) 462 - 464 Final Decision

Communication to the Court from the Registry dated 28-OCT-2013 re: IDs 54 and 55

Letter from Applicant (e-mail message) dated 24-OCT-2013 attaching a revised draft Order further to the letter dated 23-OCT-2013 received on 24-OCT-2013

Letter from Applicant dated 23-OCT-2013 with regard to hearing dates and attaching a draft Order. received on 23-OCT-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 26 Transmitted by e-mail on 19-JUN-2013: receipt acknowledged by the Applicant and the Respondent Cobalt Pharmaceuticals Company on 19-JUN-2013; by the Respondent Minister of Health on 20-JUN-2013. placed on file on 20-JUN-2013

Order dated 19-JUN-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 07-JUN-2013 Result: granted 1. The time for completing cross-examinations on affidavits is extended to 20-SEP-2013. 2. The parties shall request expedited transcripts for the final two cross-examinations scheduled for 18-SEP-2013 and 20-SEP-2013. 3. The Applicant's Record and Memoranda of Fact and Law shall be served and filed by 1-NOV-2013. 4. The Respondent Cobalt's Record and Memoranda of Fact and Law shall be served and filed by 6-DEC-2013. Filed on 19-JUN-2013 copies sent to parties entered in J. & O. Book, volume 1197 page(s) 58 - 60 Interlocutory Decision

Communication to the Court from the Registry dated 11-JUN-2013 re: Letter dated 7-JUN-2013

Draft Order concerning further to the letter from the Applicants dated June 7, 2013 received on 07-JUN-2013

Letter from Applicant dated 07-JUN-2013 further to the Direction of the Court dated June 4, 2013 providing a revised schedule agreed to by all parties that would have both records served and filed by December 6, 2013 and requesting on consent the variance of the Orders dated September 17, 2012 and June 1, 2013. The parties advise that they are available for a case management conference to discuss the draft Order at the Court's request. received on 07-JUN-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 04-JUN-2013 directing that "Even assuming that the last transcript of cross-examination can be received as early as 23-SEP-2013, the current schedule, if extended in accordance with the parties' request, would not see the Respondent's Record filed before 23-DEC-2013. Bearing in mind the Christmas period, that schedule does not afford sufficient time to the Court to prepare for the hearing, scheduled to commence on 27-JAN-2014. Unless the parties can, on consent, suggest a schedule that would see the last Record served and filed no later than 6-DEC-2013, a formal Motion, justifying the extension of time sought, will have to be made." placed on file on 04-JUN-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 04-JUN-2013 re: letter dated 3-JUN-2013

Letter from Applicant dated 03-JUN-2013 on behalf of all parties, requesting an extension of time until 20-SEP-2013 to complete cross-examinations (with respect to the '895 and '937 Patents) Draft order enclosed. received on 03-JUN-2013

Solicitor's certificate of service on behalf of Livia Aumand confirming service of the Validity Evidence of the Applicant upon The Respondent, Cobalt Pharmaceuticals Company by email on consent on 20-FEB-2013 confirming service the Validity Evidence of the Applicant upon the Respondent, Minister of Health by email on consent on 20-FEB-2013 confirming service the Validity Evidence of the Applicant upon the Respondent Patentee, Novartis AG by personal service on 20-FEB-2013 confirming service the Validity Evidence of the Applicant upon the Respondent Patentee, Roche Diagnostics GmbH by personal service on 20-FEB-2013 filed on 20-FEB-2013

Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 24). placed on file on 13-FEB-2013

Order (time and place) dated 12-FEB-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 27-JAN-2014 to begin at 09:30 duration: 3d language: E Filed on 13-FEB-2013 cc's sent to parties entered in J. & O. Book, volume 1183 page(s) 464 - 465 Transmittal letters placed on file

Communication to the Court from the Registry dated 24-JAN-2013 re: File sent to TrialJA to set down hearing date

Solicitor's certificate of service on behalf of Livia Aumand confirming service of doc. 22 upon all parties by telecopier on 23-JAN-2013 filed on 23-JAN-2013

Requisition for hearing - Application from Applicant filed on 23-JAN-2013 Tariff Application or appeal - $50.00

Solicitor's certificate of service on behalf of Kavita Ramamoorthy confirming service of 895 & 973 patents (order dated 17-Sep-2012) upon Applicant & Respondent (minister of health) by courier on 15-NOV-2012 filed on 16-NOV-2012

Acknowledgment of Receipt received from all parties with respect to Amended Protective Order Doc. 20 placed on file on 10-OCT-2012

Amended Protective Order rendered on 09-OCT-2012 by Mireille Tabib, Prothonotary filed on 10-OCT-2012 Matter considered without personal appearance amending Doc. 16 by adding para. 5(b): "the ANDS, or portions thereof..." entered in J. & O. Book, volume 1170 page(s) 275 - 284 Interlocutory Decision copies sent to parties

Communication to the Court from the Registry dated 09-OCT-2012 re: Letter dated 4-OCT-2012

Consent on behalf of all parties to the amendment of the Protective Order, attached as Schedule "A" filed on 04-OCT-2012

Letter from Respondent dated 04-OCT-2012 "The parties have agreed to an amendment to the Protective Order dated June 21, 2012...Enclosed is a draft amended Protective Order...and a signed consent. On behalf of the parties, we respectfully request the issuance of the amended Protective Order..." received on 04-OCT-2012

Acknowledgment of Receipt received from all parties with respect to Order Doc. 18 Transmitted by e-mail on 17-SEP-2012: receipt acknowledged by Cobalt on 17-SEP-2012; the Minister on 18-SEP-2012 and the Applicant & Respondent Patentees (upon reminder) on 21-SEP-2012 placed on file on 21-SEP-2012

Order dated 17-SEP-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Cobalt Pharmaceuticals Company dated 11-SEP-2012 Result: granted in part "1. The Respondent Cobalt Pharmaceuticals Company's ("Cobalt") evidence on invalidity with respect to the '895 and '937 Patents shall be served no later than 16-NOV-2012. 2. The Applicant's evidence on invalidity with respect to the '895 and '937 Patents shall be served no later than 20-FEB-2013. 3. Any Motion for leave to serve reply evidence shall be served and filed by 1-MAR-2013. 4. The Applicant shall serve and file a Requisition for Hearing no later than 23-JAN-2013. 5. Cross-examinations shall be completed no later than 6-JUN-2013. 6. The remainder of the Order of 1-JUN-2012 remains unchanged." Filed on 17-SEP-2012 copies sent to parties entered in J. & O. Book, volume 1168 page(s) 265 - 267 Interlocutory Decision

Communication to the Court from the Registry dated 12-SEP-2012 re: Letter dated 11-SEP-2012

Letter from Respondent Cobalt Pharmaceuticals Company dated 11-SEP-2012 on consent of the corporate parties, requesting amendments to the schedule with respect to the '895 and '937 Patents. received on 11-SEP-2012

Solicitor's certificate of service on behalf of Cristin Wagner confirming service of the Factual Evidence of the Applicant (Novartis Pharmaceuticals Canada Inc.) upon Respondent Patentee (Novartis AG and Roche Diagnostics GmbH) by personal service on 28-JUN-2012 confirming service the Factual Evidence upon the Respondent (Cobalt Pharmaceuticals Company) by courier on 28-JUN-2012 confirming service the Factual Evidence upon the Respondent (Minister of Health) by courier on 28-JUN-2012 filed on 29-JUN-2012

Acknowledgment of Receipt received from all parties with respect to Protective Order Doc. 16 placed on file on 22-JUN-2012

Protective Order dated 21-JUN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 14-JUN-2012 Result: granted (Order also issued in T-724-12) Filed on 21-JUN-2012 copies sent to parties entered in J. & O. Book, volume 1161 page(s) 233 - 241 Interlocutory Decision

Communication to the Court from the Registry dated 15-JUN-2012 re: Letter dated 14-JUN-2012

Letter from Applicant dated 14-JUN-2012 enclosing a draft protective order agreed to by the parties received on 14-JUN-2012

Acknowledgment of Receipt received from all parties with respect to doc.15 by email on June 1, 2012 placed on file on 01-JUN-2012

Order dated 01-JUN-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 31-MAY-2012 Result: granted "1. The Applicant's factual evidence on invalidity with respect to Canadian Patents 1,338,895 and 1,338,937 shall be served no later than 29-JUN-2012. 2. The Respondent Cobalt Pharmaceuticals Company's ("Cobalt") evidence on invalidity with respect to the '895 and '937 Patents shall be served no later than 5-OCT-2012. 3. The Applicant's evidence on invalidity with respect to the '895 and '937 Patents shall be served no later than 16-JAN-2013. 4. Any Motion for leave to serve reply evidence shall be served and filed by 23-JAN-2013. 5. The Applicant shall serve and file a Requisition for Hearing no later than 23-JAN-2013. 6. Cross-examinations shall be completed no later than 23-APR-2013. 7. The parties shall serve and file in Court File T-724-12 a single joint record of the evidence with respect to the '895 and '937 Patents, which shall be deemed to have been filed in T-723-12. The parties shall file separate Memoranda of Fact and Law in each of Court Files T-723-12 and T-724-12. 8. The Applicant's Record and Memoranda of Fact and Law shall be served and filed within 45 days of the receipt of the last cross-examination transcript (provided that the parties agree that the transcript be ordered immediately after the last cross-examination). 9. The parties shall advise the Court promptly of the date on which the last cross-examination transcript is received. 10. The Respondent Cobalt's Record and Memorandum of Fact and Law shall be served and filed no later than 45 days following service of the Applicant's Record." Same Order issued in T-724-12. Filed on 01-JUN-2012 copies sent to parties entered in J. & O. Book, volume 1159 page(s) 333 - 336 Interlocutory Decision

Communication to the Court from the Registry dated 01-JUN-2012 re: Letter dated 31-MAY-2012

Acknowledgment of Receipt received from all parties by e-mail with respect to Order Doc. 14 placed on file on 30-MAY-2012

Letter from Applicant dated 31-MAY-2012 on behalf of all parties enclosing an agreed upon draft scheduling order for the steps to be taken in these applications. received on 31-MAY-2012

Order dated 30-MAY-2012 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "1. With the exception of the issues relating to Canadian Patent 2,410,201 in Court file T-724-12, which have been severed, all issues in these applications are to be heard and determined together, and on the basis of common evidence." (Same Order issued in T-724-12) Filed on 30-MAY-2012 copies sent to parties entered in J. & O. Book, volume 1159 page(s) 209 - 210 Interlocutory Decision

Ottawa 30-MAY-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the overlap with respect to the Patents in T-723-12 and T-724-12. Parties are requesting that the '895 and '937 Patents be heard together, and that the issues with respect to the '201 Patent in T-724-12 be heard separately. Result of Hearing: An Order will issue. Parties will provide a joint proposed schedule for T-723-12 and T-724-12. held in chambers by way of Conference Call Duration per day: 30-MAY-2012 from 10:00 to 10:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 15min Appearances: Tony Creber/Livia Aumand 613-786-0140 representing Applicant Michael Migus 416-941-9398 representing Respondent Comments: Heard together with T-724-12 Minutes of Hearing entered in Vol. 863 page(s) 74 - 77 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-MAY-2012 directing that A case management telephone conference will be held beginning at 10:00a.m. on May 30, 2012. placed on file on 14-MAY-2012 Confirmed in writing to the party(ies)

Letter from Applicant dated 10-MAY-2012 on behalf of all parties, respectfully submitting that it would not be an effective use of time and resources to litigate the patents (T-723-12 & T-724-12) in both applications...As many issues in T-1420-11 are common to those in respect of the '895 and '937 Patents in T-723-12 and T-724-12, it is anticipated that the preparation of the Applicant's factual evidence in T-723-12 and T-724-12 with respect to these two patents can be handled relatively quickly. Parties jointly propose that the issues in T-723-12 and T-724-12 with respect to the '895 and '937 Patents be heard together, and that the issues with respect to the '201 Patent be heard seperately... The parties are available for a case management teleconference on May 17,18, 21,28 and 30, 2012. The Minister of Health will not be participating. Paties hope to provide the Court with a proposal regarding schedules shortly received on 10-MAY-2012

Communication to the Court from the Registry dated 09-MAY-2012 re: Newly case managed NOC. Requires a schedule. Note: Letter of May 10th providing update and dates for CMC added to this memo)

Successful transmission received from facsmile with respect to the Order of the Court rendered on April 14, 2012, communicated to all parties. placed on file on 13-APR-2012

Affidavit of service of James Adeney sworn on 13-APR-2012 on behalf of Respondent (Minister) confirming service of doc 12 upon all parties by telecopier on 13-APR-2012 with Exhibits A filed on 13-APR-2012

Notice of appearance on behalf of Respondent (Minister) filed on 13-APR-2012

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of 10 upon the Applicant and the Respondent, Novartis AG by personal service on 13-APR-2012 confirming service 10 upon the Respondent, Cobolt Pharmaceuticals Company and the Minister of Health by telecopier on 13-APR-2012 filed on 13-APR-2012

Notice of appearance on behalf of the Respondent, ROCHE DIAGNOSTICS GmbH filed on 13-APR-2012

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of 8 upon the Applicant and the Respondent, Roche Diagnostics GmbH by personal service on 13-APR-2012 confirming service 8 upon the Respondents, Cobalt Pharmaceuticals Company and the Minister of Health by telecopier on 13-APR-2012 filed on 13-APR-2012

Notice of appearance on behalf of the Respondent, NOVARTIS AG filed on 13-APR-2012

Affidavit of service of Natalie Sirota sworn on 10-APR-2012 on behalf of Applicant confirming service of doc # 1 upon the Respondent, Cobalt Pharmaceuticals Company by personal service on 10-APR-2012 filed on 13-APR-2012

Affidavit of service of Erin McIntomny sworn on 12-APR-2012 on behalf of Applicant confirming service of doc # 1 upon the Respondent, Minister of Health by personal service on 05-APR-2012 confirming service doc # 1 upon the Respondent, Novartis AG by personal service on 05-APR-2012 confirming service doc # 1 upon the Respondent, Roche Diagnostics GmbH by personal service on 05-APR-2012 filed on 13-APR-2012

Order dated 12-APR-2012 rendered by Acting Chief Justice S Noël Matter considered without personal appearance The Court's decision is with regard to Special Case Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter." Filed on 12-APR-2012 entered in J. & O. Book, volume 1154 page(s) 109 - 109 Interlocutory Decision

Solicitor's certificate of service on behalf of Michael Migus confirming service of doc 3 upon all parties by telecopier on 12-APR-2012 filed on 12-APR-2012

Notice of appearance on behalf of Respondent (Cobalt) filed on 12-APR-2012

Service copy of Doc. No. 1 with proof of service upon the Deputy Attorney General of Canada on 10-APR-2012 filed on 10-APR-2012

Notice of application and 2 copies with regard to section 55.2(4) of the Patent Act and section 6 of Patented Medicines (NOC) filed on 05-APR-2012 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes